MOG and neuromyelitis optica: The localization of specific brainstem lesions may also have diagnostic value in distinguishing MS from clinically similar entities like myelin oligodendrocyte glycoprotein (MOG)-associated disease or neuromyelitis optica spectrum disorder (NMOSD).